EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell Lung Cancer

Yonghua Ye, Yuping Yang, Li Yan, Li Zhou iD, Shihui Yu, Quan Du, Xiaoqiao Dong, Qiang Yuan, Letian Shan iD, Le Guo

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s414098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Yonghua Ye und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Artemisia annua, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungArtemisia annuaLung NeoplasmsHumansAnimalsZebrafishNetwork PharmacologyPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTandem Mass SpectrometryArtemisinins

Stichwörter der Autor:innen

Qinghao Biejia decoctionartemisinin Blarval zebrafishnetwork pharmacologynon-small-cell lung cancer

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktartemisinin BArtemisininsartemisinin

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
  • The First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
  • Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Cell Resource Bank and Integrated Cell Preparation Center of Xiaoshan District, Hangzhou Regional Cell Preparation Center (Shangyu Biotechnology Co., Ltd), Hangzhou, People's Republic of China.

ORCID-Profile: Li Zhou, Letian Shan

Zitieren

APA

Ye, Y., Yang, Y., Yan, L., Zhou, L., Yu, S., Du, Q., Dong, X., Yuan, Q., Shan, L., & Guo, L. (2023). Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell Lung Cancer. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s414098

Vancouver

Ye Y, Yang Y, Yan L, Zhou L, Yu S, Du Q, et al. Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell Lung Cancer. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s414098

BibTeX
@article{Ye2023,
  author = {Ye, Yonghua and Yang, Yuping and Yan, Li and Zhou, Li and Yu, Shihui and Du, Quan and Dong, Xiaoqiao and Yuan, Qiang and Shan, Letian and Guo, Le},
  title = {Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell Lung Cancer},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s414098}
}
Kostenlos starten →